Method of administering amantadine prior to a sleep period

US9877933B2 · kind B2 · utility

Assignee

• Adamas Pharma, LLC · US

Inventors

• Gregory T. Went · Mill Valley, US
• Gayatri Sathyan · Bengaluru, IN
• Kavita Vermani · Fremont, US
• Gangadhara Ganapati · Palo Alto, US
• Michael Coffee · Easton, US
• Efraim Shek · Pleasanton, US
• Ashok Katdare · Berkeley, US

Key dates

• Filing date: Feb 9, 2017
• Grant date: Jan 30, 2018
• Expiry date: Feb 9, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.